Stock listing

Xetra:LT4 Liquidia Corporation Aktie

German listing (Xetra) of Liquidia Corporation · home listing NASDAQ:LQDA

Follow Liquidia Corporation into a list and get an email when it puts out news.

Home listing price · NASDAQ:LQDA

$54.43 USD -1.97 (-3.5%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:LQDA

Past year +90.6% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$53.98 – $57.21 USDNov 20, 2026
Volume
1.69M sharesNov 20, 2026
Market cap
$4.90B USDAt the close on Nov 20, 2026 · price × 90.11M shares outstanding
52-week range
$22.31 – $93.61 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$140.0M USDMedian day 1.87M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Liquidia Corporation logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:LQDA · Home$54.43 USD-1.97 (-3.5%)1,690,880$56.49$57.21$53.98$56.40Close on Nov 20, 2026
Frankfurt:LT4€51.08 EUR-0.30 (-0.6%)—€51.08€51.08€51.08€51.38Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:LQDA · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$54.43-1.97-3.5%$56.49$57.21$53.981,690,880
$56.40-0.33-0.6%$57.27$58.82$55.801,217,969
$56.73+0.36+0.6%$56.49$57.21$54.801,804,679
$56.37-1.04-1.8%$57.00$58.08$55.851,766,109
$57.41-0.71-1.2%$58.37$59.49$57.001,870,344
$58.12+2.91+5.3%$55.00$58.74$54.012,809,779
$55.21+3.81+7.4%$54.00$56.79$52.763,777,378
$51.40+3.53+7.4%$48.73$51.69$46.242,847,088
$47.87+3.47+7.8%$45.60$48.24$45.092,157,757
$44.40-0.09-0.2%$44.60$45.69$44.231,291,366
$44.49-2.89-6.1%$47.38$47.46$44.391,949,560
$47.38+5.18+12.3%$43.32$51.11$43.244,808,598
$42.20+0.35+0.8%$41.69$43.37$41.582,182,208
$41.85-3.21-7.1%$45.71$45.71$41.662,582,625
$45.06+0.07+0.2%$44.99$46.29$44.242,090,619
$44.99-0.73-1.6%$46.23$47.20$44.412,609,056
$45.72+0.28+0.6%$45.40$47.18$45.002,235,901
$45.44+1.70+3.9%$43.88$46.36$43.703,145,646
$43.74+1.09+2.6%$42.77$45.72$42.124,113,322
$42.65+2.96+7.5%$39.86$42.83$38.693,800,500
$39.69+0.83+2.1%$38.75$40.08$38.223,532,000
$38.86+2.51+6.9%$36.65$39.20$36.513,878,500
$36.35+2.22+6.5%$33.90$36.93$33.653,993,600
$34.13-0.22-0.6%$34.42$36.82$33.763,026,100
$34.35-0.43-1.2%$34.78$34.90$33.334,548,200
$34.78+0.84+2.5%$34.93$35.80$32.207,220,200
$33.94+7.13+26.6%$35.70$38.64$33.1221,143,400
$26.81-0.86-3.1%$27.04$27.40$26.137,653,300
$27.67+0.29+1.1%$29.27$30.86$27.284,413,100
$27.38-0.64-2.3%$27.06$28.53$26.673,617,000
$28.02+1.34+5.0%$26.34$29.35$26.345,259,500
$26.68+0.77+3.0%$25.55$27.33$24.596,982,200
$25.91-1.73-6.3%$27.95$28.30$25.765,307,000
$27.64-1.00-3.5%$28.07$28.48$25.927,755,100
$28.64+0.65+2.3%$26.69$29.18$26.318,394,700
$27.99-2.27-7.5%$23.96$28.10$22.3121,573,300
$30.26-40.43-57.2%$70.54$71.93$29.8622,953,200
$70.69-2.98-4.0%$72.49$73.15$68.741,532,900
$73.67+5.24+7.7%$68.05$74.74$67.661,206,300
$68.43-2.52-3.6%$71.60$71.81$67.55967,300
$70.95+3.46+5.1%$67.04$71.41$66.751,026,100
$67.49-1.15-1.7%$68.60$68.60$67.10765,900
$68.64+2.21+3.3%$66.59$68.76$66.001,139,000
$66.43-0.45-0.7%$67.18$67.41$65.741,010,200
$66.88-1.51-2.2%$68.08$68.72$66.573,895,700
$68.39-0.06-0.1%$69.51$70.81$67.411,082,300
$68.45+2.73+4.2%$65.67$69.87$65.341,296,400
$65.72+0.41+0.6%$65.31$65.93$62.861,372,100
$65.31-1.43-2.1%$66.79$66.90$65.131,074,400
$66.74-1.11-1.6%$68.66$69.94$66.68778,500
$67.85-1.27-1.8%$67.87$68.35$66.62955,000
$69.12+1.44+2.1%$67.39$69.39$67.35997,300
$67.68-0.98-1.4%$68.00$69.21$67.071,329,000
$68.66+0.030.0%$67.91$69.47$67.40900,200
$68.63-1.05-1.5%$69.27$70.75$68.15931,700
$69.68+2.77+4.1%$67.40$70.13$66.731,282,600
$66.91-1.26-1.8%$67.70$69.00$66.101,410,000
$68.17+0.48+0.7%$67.10$68.27$66.101,054,400
$67.69-2.25-3.2%$69.99$70.31$67.57926,300
$69.94-1.42-2.0%$71.01$71.70$69.51548,700
$71.36+0.87+1.2%$70.14$72.96$70.00846,000
$70.49+0.22+0.3%$71.50$73.07$70.10931,000
$70.27+1.65+2.4%$67.77$71.11$67.251,291,300
$68.62-2.43-3.4%$70.91$71.13$68.051,698,900
$71.05-4.28-5.7%$73.55$74.53$70.851,583,500
Ticker
Xetra:LT4
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Xetra
Currency
EUR

What changed lately

Latest news

All Liquidia Corporation news

Liquidia Corporation on 6ix

Sector
Health care
Industry
Biotechnology
News releases
21 in the last 12 months · 196 in all · newest Nov 10, 2026 · oldest 2019
Calls
23 calls with a replay · 23 with a transcript · latest Nov 10, 2026
Decks
10 decks · latest Nov 10, 2026

Where Liquidia Corporation is listed

ListingExchangeCountryCurrency
NASDAQ:LQDA · Home listingNASDAQUnited StatesUSD
gettex:LT4gettexGermanyEUR
Tradegate:LT4TradegateGermanyEUR
LS Exchange:A2JRNSLS ExchangeGermanyEUR
Lang & Schwarz:A2JRNSLang & SchwarzGermanyEUR
BOATS:LQDABOATSUnited StatesUSD
Frankfurt:LT4FrankfurtGermanyEUR
Stuttgart:LT4StuttgartGermanyEUR
Dusseldorf:LT4DusseldorfGermanyEUR
Munich:LT4MunichGermanyEUR
Hamburg:LT4HamburgGermanyEUR
Hanover:LT4HanoverGermanyEUR
Xetra:LT4 · This pageXetraGermanyEUR

Valuation

EV/sales 7.5× against a median of 5.7×: 6th lowest of 7 Biotechnology companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$4.68B USD
P/E
Loss
EV/sales
7.5×
EV/EBITDA
Negative EBITDA
Price/book
Negative equity
Gross margin
92.7%
Operating margin
−15.6%
Net margin
−15.2%
Debt to equity
Negative equity
Beta vs S&P 500
0.84

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Liquidia Corporation · NASDAQ:LQDAUS$4.90BUS$4.68Bn/a7.5×n/an/a−15.2%n/a0.84
Belite Bio, Inc. · NASDAQ:BLTEUS$5.13BUS$5.13Bn/an/an/a6.6×n/a0.0×1.34
SK Biopharmaceuticals Co., Ltd. · KRX:326030US$5.05BUS$4.77B16.9×7.5×20.1×6.7×46.6%0.0×n/a
Veradermics, Incorporated · NYSE:MANEUS$5.04BUS$4.25Bn/an/an/a6.3×n/a0.0×1.13
Erasca, Inc. · NASDAQ:ERASUS$4.78BUS$4.18Bn/an/an/a5.2×n/a0.1×1.51
Dianthus Therapeutics, Inc. · NASDAQ:DNTHUS$4.76BUS$3.92Bn/a1,444×n/a3.8×n/a0.0×0.90
PTC Therapeutics, Inc. · NASDAQ:PTCTUS$4.71BUS$3.12Bn/a2.7×n/an/a−9.2%n/a0.88
Cogent Biosciences, Inc. · NASDAQ:COGTUS$4.65BUS$4.08Bn/an/an/a9.0×n/a0.4×1.30
Kiniksa Pharmaceuticals International, plc · NASDAQ:KNSAUS$4.53BUS$3.97B41.4×4.2×29.9×6.4×11.6%0.0×0.57
Travere Therapeutics, Inc. · NASDAQ:TVTXUS$4.51BUS$4.21Bn/a6.5×n/a200×−18.7%0.0×1.31
Ionis Pharmaceuticals, Inc. · NASDAQ:IONSUS$4.43BUS$4.70Bn/a4.9×n/a11.3×−56.9%5.5×0.40
Median of the othersUS$4.74BUS$4.19B29.2×5.7×25.0×6.6×−9.2%0.0×1.13

Forecasts

5 strong buy · 1 buy · 2 hold · Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.

Price target
66.13 USD · Analysts' mean
EPS, year to Dec 2026
0.075 · 2 analysts
Revenue, year to Dec 2026
759.6M · 5 analysts

Team and board

Officers

OfficerRole
Roger JeffsChief Executive Officer
Patrick WallaceDirector, Corporate Communications
Jason AdairChief Business Officer

Board

DirectorRole
Stephen BlochChairman
Arthur KirschBoard Member
Damian deGoaBoard Member
David JohnsonBoard Member
Joanna HorobinBoard Member
Katie Rielly-GauvinBoard Member
Paul ManningBoard Member
Raman SinghBoard Member
Roger JeffsChief Executive Officer

Events

Calls

CallWhenStatus
Liquidia (NASDAQ:LQDA) Q3 2026 Earnings CallTue, Nov 10, 2026 · 8:30 AM ETReplay
Liquidia (NASDAQ:LQDA) Q2 2026 Earnings CallWed, Aug 12, 2026 · 8:30 AM ETReplay
Liquidia (NASDAQ:LQDA) Q1 2026 Earnings CallMon, May 11, 2026 · 8:30 AM ETReplay
Liquidia (NASDAQ:LQDA) Q4 2025 Earnings CallThu, Mar 05, 2026 · 8:30 AM ETReplay
Liquidia (NASDAQ:LQDA) Q3 2025 Earnings CallMon, Nov 03, 2025 · 8:30 AM ETReplay
Liquidia (NASDAQ:LQDA) Q2 2025 Earnings CallTue, Aug 12, 2025 · 8:30 AM ETReplay
Liquidia (NASDAQ:LQDA) Q1 2025 Earnings CallThu, May 08, 2025 · 8:30 AM ETReplay
Liquidia (NASDAQ:LQDA) Q4 2024 Earnings CallWed, Mar 19, 2025 · 8:30 AM ETReplay
Liquidia (NASDAQ:LQDA) Q3 2024 Earnings CallWed, Nov 13, 2024 · 8:30 AM ETReplay
Liquidia (NASDAQ:LQDA) Q2 2024 Earnings CallWed, Aug 07, 2024 · 8:30 AM ETReplay
All 23 calls
CallWhenStatus
Liquidia (NASDAQ:LQDA) Q1 2024 Earnings CallTue, May 14, 2024 · 8:30 AM ETReplay
Liquidia (NASDAQ:LQDA) Q4 2023 Earnings CallWed, Mar 13, 2024 · 8:30 AM ETReplay
Liquidia (NASDAQ:LQDA) Q3 2023 Earnings CallTue, Nov 07, 2023 · 8:30 AM ETReplay
Liquidia (NASDAQ:LQDA) Q2 2023 Earnings CallThu, Aug 10, 2023 · 8:30 AM ETReplay
Liquidia (NASDAQ:LQDA) Q1 2023 Earnings CallThu, May 04, 2023 · 8:30 AM ETReplay
Liquidia (NASDAQ:LQDA) Q4 2022 Earnings CallThu, Mar 16, 2023 · 8:30 AM ETReplay
Liquidia (NASDAQ:LQDA) Q3 2022 Earnings CallTue, Nov 08, 2022 · 8:30 AM ETReplay
Liquidia (NASDAQ:LQDA) Q2 2022 Earnings CallThu, Aug 11, 2022 · 8:30 AM ETReplay
Liquidia (NASDAQ:LQDA) Q1 2022 Earnings CallThu, May 12, 2022 · 8:30 AM ETReplay
Liquidia (NASDAQ:LQDA) Q4 2021 Earnings CallThu, Mar 17, 2022 · 8:30 AM ETReplay
Liquidia (NASDAQ:LQDA) Q2 2021 Earnings CallTue, Aug 10, 2021 · 8:30 AM ETReplay
Liquidia (NASDAQ:LQDA) Q1 2021 Earnings CallThu, May 13, 2021 · 8:30 AM ETReplay
Liquidia (NASDAQ:LQDA) Q4 2020 Earnings CallTue, Mar 23, 2021 · 8:30 AM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 10, 2026 · Before open+7.4%
Q2 2026Aug 12, 2026 · Before open−10.5%
Q1 2026May 11, 2026 · Before open+25.6%
Q4 2025Mar 12, 2026−4.9%
Q3 2025Nov 3, 2025 · Before open+3.5%
Q2 2025Aug 12, 2025 · Before open+13.7%
Q1 2025May 8, 2025 · Before open−1.2%
Q4 2024Mar 19, 2025+4.8%
Q3 2024Nov 13, 2024 · Before open−3.4%
Q2 2024Aug 7, 2024 · Before open−3.4%
All 20 quarters
QuarterResultsShare move
Q1 2024May 13, 2024 · After close−1.5%
Q4 2023Mar 13, 2024 · Before open+5.4%
Q3 2023Nov 7, 2023 · Before open+3.7%
Q2 2023Aug 10, 2023 · Before open+3.1%
Q1 2023May 4, 2023 · After close+1.1%
Q4 2022Mar 16, 2023 · Before open+15.3%
Q3 2022Nov 8, 2022 · After close+0.4%
Q2 2022Aug 11, 2022 · After close+27.9%
Q1 2022May 12, 2022 · After close+13.9%
Q4 2021Mar 17, 2022 · Before open+5.0%

Open Events

Decks

DeckKindSlidesDate
Q3 2026 Earnings PresentationEarnings10 slidesNov 10, 2026
Q2 2026 Earnings PresentationEarnings12 slidesAug 12, 2026
Q1 2026 Earnings PresentationEarnings10 slidesMay 11, 2026
Q4 2025 Earnings PresentationEarnings8 slidesMar 5, 2026
J.P. Morgan Healthcare Conference 2026Conference21 slidesJan 14, 2026
Q3 2025 Earnings PresentationEarnings9 slidesNov 3, 2025
Investor Day (October 2025)Investor day62 slidesOct 28, 2025
Q2 2025 Earnings PresentationEarnings9 slidesAug 12, 2025
Corporate Update (May 2025)Corporate update12 slidesMay 27, 2025
J.P. Morgan Healthcare Conference 2025Conference22 slidesJan 15, 2025

Open Decks

Financings

RaiseDate
Royalty financing (sixth amendment to HCRx agreement)
Tranche closed: US$50M raised
Buyers: HealthCare Royalty (HCRx) (funded an additional $50.0 million)
Use of proceeds: Accelerate YUTREPIA launch, advance clinical pipeline, and expand manufacturing including build-out of newly leased facility
Jun 23, 2025

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue158.3M14.0M17.5M15.9M12.9M739.6K8.07M2.71M7.26M13.2M
Cost of revenue13.2M5.88M2.89M2.86M3.02M237.7K807.2K121.4K319.8K918.8K
Gross profit145.1M8.12M14.6M13.1M9.83M501.9K7.26M2.59M6.94M12.3M
Research and development39.3M47.8M43.2M19.4M20.5M32.2M40.5M28.7M24.8M23.3M
Selling, general and administrative157.2M81.6M44.7M32.4M23.1M27.4M13.6M8.75M10.2M4.84M
Operating income-51.4M-121.3M-73.4M-38.8M-33.8M-59.1M-46.8M-34.9M-28.0M-15.9M
Depreciation and amortization1.53M2.20M2.18M3.65M5.61M3.13M2.57M1.54M931.9K651.6K
EBITDA-49.8M-119.1M-71.2M-35.1M-28.2M-56.0M-44.3M-33.3M-27.1M-15.2M
Interest expense24.2M14.7M6.27M2.34M762.0K858.0K1.37M19.0M13.0M85.9K
Income before tax-68.9M-130.4M-78.5M-41.0M-34.6M-59.8M-47.6M-53.1M-29.2M-15.9M
Income tax0000000720.4K13.0M14.9K
Net income-68.9M-128.3M-78.5M-41.0M-34.6M-59.8M-47.6M-53.1M-29.2M-15.9M
Earnings per share, basic-0.80-1.63-1.21-0.67-0.70-1.76-2.57-7.42-3.40-3.13
Earnings per share, diluted-0.80-1.63-1.21-0.67-0.70-1.76-2.57

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents190.7M176.5M83.7M93.3M57.5M65.3M55.8M39.5M3.42M1.44M
Receivables54.1M2.72M4.06M5.02M2.99M0272.6K1.62M1.24M
Inventory23.8M241.0K1111
Current assets273.4M185.1M89.9M99.8M61.3M66.1M56.4M40.0M5.48M3.15M
Property, plant and equipment11.8M8.30M4.48M4.15M5.02M6.81M9.25M8.13M8.24M4.35M
Goodwill3.90M3.90M3.90M3.90M3.90M3.90M0
Total assets327.9M230.3M118.3M129.2M93.7M99.5M68.8M49.4M14.8M8.49M
Accounts payable3.68M4.69M1.40M2.20M1.07M3.73M3.50M3.24M4.42M2.41M
Current liabilities135.8M41.8M18.6M8.80M7.33M11.7M16.9M8.25M30.5M12.1M
Long-term debt132.9M97.4M43.4M19.9M10.4M10.3M10.3M11.6M5.56M5.22M
Total debt197.9M122.4M49.5M19.9M10.4M10.3M15.9M12.8M23.5M8.68M
Total liabilities283.2M150.9M71.0M38.8M28.5M28.4M33.9M30.7M48.5M26.7M
Shareholders' equity44.7M79.4M47.3M90.4M65.3M71.1M34.9M18.7M-33.7M-18.2M
Shares outstanding87.2M84.7M68.6M64.5M52.3M43.3M28.2M7.16M8.59M5.09M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-35.7M-93.4M-41.6M-28.6M-34.0M-54.1M-48.3M-31.8M-24.3M-13.9M
Capital spending-4.34M-4.95M-1.29M-592.0K-107.0K-752.1K-1.85M-870.9K-2.54M-2.89M
Free cash flow-40.0M-98.4M-42.9M-29.2M-34.1M-54.9M-50.1M-32.7M-26.8M-16.8M
Cash from investing-6.34M-8.44M-11.3M-587.0K-107.0K247.9K-1.85M-870.9K-2.54M-2.89M
Cash from financing59.7M194.7M43.2M65.0M26.3M63.4M66.4M68.8M28.8M6.11M
Share buybacks62.4M72.8M96.7K445.5K
Change in cash17.7M92.8M-9.60M35.8M-7.82M9.52M16.3M36.1M1.98M-10.7M

Open Financials

Filings

FilingDateTypeFiled with
SCHEDULE 13G · Big-stake noticeNov 19, 2026Big-stake noticeSEC
4 · Change in ownershipNov 18, 2026Insider tradeSEC
4 · Change in ownershipNov 18, 2026Insider tradeSEC
4 · Change in ownershipNov 18, 2026Insider tradeSEC
3 · Initial statement of ownershipNov 18, 2026Insider tradeSEC
8-K · Current reportNov 18, 2026Management or board changeSEC
8-K · Current reportNov 10, 2026ResultsSEC
10-Q · Quarterly reportNov 10, 2026Quarterly reportSEC
4 · Change in ownershipOct 28, 2026Insider tradeSEC
4 · Change in ownershipOct 28, 2026Insider tradeSEC
Show 200 filings
FilingDateTypeFiled with
8-K · Current reportOct 13, 2026Material contractSEC
4 · Change in ownershipOct 13, 2026Insider tradeSEC
4 · Change in ownershipOct 13, 2026Insider tradeSEC
4 · Change in ownershipOct 13, 2026Insider tradeSEC
4 · Change in ownershipOct 13, 2026Insider tradeSEC
4 · Change in ownershipOct 13, 2026Insider tradeSEC
4 · Change in ownershipOct 13, 2026Insider tradeSEC
4 · Change in ownershipOct 13, 2026Insider tradeSEC
4 · Change in ownershipOct 13, 2026Insider tradeSEC
4 · Change in ownershipOct 13, 2026Insider tradeSEC
4 · Change in ownershipOct 7, 2026Insider tradeSEC
8-K · Current reportSep 30, 2026Current reportSEC
4 · Change in ownershipSep 15, 2026Insider tradeSEC
144 · Notice of proposed saleSep 14, 2026Other filingsSEC
144 · Notice of proposed saleSep 11, 2026Other filingsSEC
4 · Change in ownershipSep 3, 2026Insider tradeSEC
8-K · Current reportSep 3, 2026Current reportSEC
4 · Change in ownershipAug 25, 2026Insider tradeSEC
144 · Notice of proposed saleAug 21, 2026Other filingsSEC
4 · Change in ownershipAug 21, 2026Insider tradeSEC
4 · Change in ownershipAug 19, 2026Insider tradeSEC
144 · Notice of proposed saleAug 19, 2026Other filingsSEC
144 · Notice of proposed saleAug 19, 2026Other filingsSEC
144 · Notice of proposed saleAug 17, 2026Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2026Big-stake noticeSEC
10-Q · Quarterly reportAug 12, 2026Quarterly reportSEC
8-K · Current reportAug 12, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 4, 2026Big-stake noticeSEC
4 · Change in ownershipJul 29, 2026Insider tradeSEC
4 · Change in ownershipJul 29, 2026Insider tradeSEC
4 · Change in ownershipJul 24, 2026Insider tradeSEC
4 · Change in ownershipJul 22, 2026Insider tradeSEC
4 · Change in ownershipJul 14, 2026Insider tradeSEC
4 · Change in ownershipJul 14, 2026Insider tradeSEC
4 · Change in ownershipJul 14, 2026Insider tradeSEC
4 · Change in ownershipJul 14, 2026Insider tradeSEC
4 · Change in ownershipJul 14, 2026Insider tradeSEC
4 · Change in ownershipJul 14, 2026Insider tradeSEC
4 · Change in ownershipJul 14, 2026Insider tradeSEC
4 · Change in ownershipJul 14, 2026Insider tradeSEC
4 · Change in ownershipJul 14, 2026Insider tradeSEC
4 · Change in ownershipJul 8, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedJul 8, 2026Big-stake noticeSEC
4 · Change in ownershipJul 6, 2026Insider tradeSEC
4 · Change in ownershipJun 24, 2026Insider tradeSEC
4 · Change in ownershipJun 18, 2026Insider tradeSEC
4 · Change in ownershipJun 18, 2026Insider tradeSEC
4 · Change in ownershipJun 18, 2026Insider tradeSEC
4 · Change in ownershipJun 18, 2026Insider tradeSEC
4 · Change in ownershipJun 18, 2026Insider tradeSEC
4 · Change in ownershipJun 18, 2026Insider tradeSEC
4 · Change in ownershipJun 18, 2026Insider tradeSEC
4 · Change in ownershipJun 18, 2026Insider tradeSEC
8-K · Current reportJun 17, 2026Meeting outcomeSEC
4 · Change in ownershipJun 16, 2026Insider tradeSEC
4 · Change in ownershipJun 15, 2026Insider tradeSEC
4 · Change in ownershipJun 12, 2026Insider tradeSEC
144 · Notice of proposed saleJun 11, 2026Other filingsSEC
144 · Notice of proposed saleJun 10, 2026Other filingsSEC
4 · Change in ownershipJun 10, 2026Insider tradeSEC
4 · Change in ownershipJun 10, 2026Insider tradeSEC
4 · Change in ownershipJun 8, 2026Insider tradeSEC
8-K · Current reportJun 8, 2026Current reportSEC
4 · Change in ownershipJun 8, 2026Insider tradeSEC
144 · Notice of proposed saleJun 8, 2026Other filingsSEC
144 · Notice of proposed saleJun 4, 2026Other filingsSEC
144 · Notice of proposed saleJun 4, 2026Other filingsSEC
4 · Change in ownershipJun 3, 2026Insider tradeSEC
4 · Change in ownershipJun 3, 2026Insider tradeSEC
144 · Notice of proposed saleJun 1, 2026Other filingsSEC
4 · Change in ownershipMay 28, 2026Insider tradeSEC
4 · Change in ownershipMay 26, 2026Insider tradeSEC
4 · Change in ownershipMay 26, 2026Insider tradeSEC
144 · Notice of proposed saleMay 21, 2026Other filingsSEC
4 · Change in ownershipMay 20, 2026Insider tradeSEC
4 · Change in ownershipMay 20, 2026Insider tradeSEC
144 · Notice of proposed saleMay 20, 2026Other filingsSEC
4 · Change in ownershipMay 15, 2026Insider tradeSEC
144 · Notice of proposed saleMay 14, 2026Other filingsSEC
4 · Change in ownershipMay 13, 2026Insider tradeSEC
4 · Change in ownershipMay 12, 2026Insider tradeSEC
144 · Notice of proposed saleMay 11, 2026Other filingsSEC
10-Q · Quarterly reportMay 11, 2026Quarterly reportSEC
8-K · Current reportMay 11, 2026ResultsSEC
144 · Notice of proposed saleMay 8, 2026Other filingsSEC
4 · Change in ownershipMay 7, 2026Insider tradeSEC
144 · Notice of proposed saleMay 7, 2026Other filingsSEC
4 · Change in ownershipApr 29, 2026Insider tradeSEC
4 · Change in ownershipApr 29, 2026Insider tradeSEC
ARS · Annual report to shareholdersApr 24, 2026Annual reportSEC
DEFA14A · Additional proxy materialApr 24, 2026Meeting noticeSEC
DEF 14A · Proxy statementApr 24, 2026Meeting noticeSEC
4 · Change in ownershipApr 21, 2026Insider tradeSEC
144 · Notice of proposed saleApr 17, 2026Other filingsSEC
4 · Change in ownershipApr 16, 2026Insider tradeSEC
4 · Change in ownershipApr 16, 2026Insider tradeSEC
144 · Notice of proposed saleApr 16, 2026Other filingsSEC
144 · Notice of proposed saleApr 15, 2026Other filingsSEC
144 · Notice of proposed saleApr 15, 2026Other filingsSEC
4 · Change in ownershipApr 14, 2026Insider tradeSEC
4 · Change in ownershipApr 14, 2026Insider tradeSEC
4 · Change in ownershipApr 14, 2026Insider tradeSEC
4 · Change in ownershipApr 14, 2026Insider tradeSEC
4 · Change in ownershipApr 14, 2026Insider tradeSEC
4 · Change in ownershipApr 14, 2026Insider tradeSEC
4 · Change in ownershipApr 14, 2026Insider tradeSEC
4 · Change in ownershipApr 14, 2026Insider tradeSEC
144 · Notice of proposed saleApr 14, 2026Other filingsSEC
4 · Change in ownershipApr 13, 2026Insider tradeSEC
4 · Change in ownershipApr 13, 2026Insider tradeSEC
144 · Notice of proposed saleApr 10, 2026Other filingsSEC
144 · Notice of proposed saleApr 10, 2026Other filingsSEC
144 · Notice of proposed saleApr 9, 2026Other filingsSEC
144 · Notice of proposed saleApr 9, 2026Other filingsSEC
4 · Change in ownershipMar 30, 2026Insider tradeSEC
144 · Notice of proposed saleMar 27, 2026Other filingsSEC
144 · Notice of proposed saleMar 26, 2026Other filingsSEC
4 · Change in ownershipMar 25, 2026Insider tradeSEC
4 · Change in ownershipMar 17, 2026Insider tradeSEC
4 · Change in ownershipMar 17, 2026Insider tradeSEC
4 · Change in ownershipMar 17, 2026Insider tradeSEC
144 · Notice of proposed saleMar 13, 2026Other filingsSEC
144 · Notice of proposed saleMar 13, 2026Other filingsSEC
144 · Notice of proposed saleMar 13, 2026Other filingsSEC
4 · Change in ownershipMar 11, 2026Insider tradeSEC
144 · Notice of proposed saleMar 9, 2026Other filingsSEC
S-3ASR · Registration statementMar 5, 2026Offer documentSEC
S-8 · Registration statement for employee plansMar 5, 2026Offer documentSEC
S-8 · Registration statement for employee plansMar 5, 2026Offer documentSEC
10-K · Annual reportMar 5, 2026Annual reportSEC
8-K · Current reportMar 5, 2026ResultsSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipFeb 12, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 9, 2026Big-stake noticeSEC
4 · Change in ownershipJan 28, 2026Insider tradeSEC
4 · Change in ownershipJan 28, 2026Insider tradeSEC
4 · Change in ownershipJan 21, 2026Insider tradeSEC
4 · Change in ownershipJan 21, 2026Insider tradeSEC
4 · Change in ownershipJan 21, 2026Insider tradeSEC
4 · Change in ownershipJan 21, 2026Insider tradeSEC
4 · Change in ownershipJan 21, 2026Insider tradeSEC
4 · Change in ownershipJan 21, 2026Insider tradeSEC
4 · Change in ownershipJan 21, 2026Insider tradeSEC
4 · Change in ownershipJan 21, 2026Insider tradeSEC
4 · Change in ownershipJan 21, 2026Insider tradeSEC
4 · Change in ownershipJan 13, 2026Insider tradeSEC
4 · Change in ownershipJan 13, 2026Insider tradeSEC
4 · Change in ownershipJan 13, 2026Insider tradeSEC
4 · Change in ownershipJan 13, 2026Insider tradeSEC
4 · Change in ownershipJan 13, 2026Insider tradeSEC
4 · Change in ownershipJan 13, 2026Insider tradeSEC
4 · Change in ownershipJan 13, 2026Insider tradeSEC
4 · Change in ownershipJan 13, 2026Insider tradeSEC
3 · Initial statement of ownershipJan 13, 2026Insider tradeSEC
8-K · Current reportJan 9, 2026Current reportSEC
4 · Change in ownershipDec 2, 2025Insider tradeSEC
4 · Change in ownershipDec 2, 2025Insider tradeSEC
4 · Change in ownershipDec 2, 2025Insider tradeSEC
4 · Change in ownershipDec 2, 2025Insider tradeSEC
4 · Change in ownershipDec 2, 2025Insider tradeSEC
4 · Change in ownershipDec 2, 2025Insider tradeSEC
4 · Change in ownershipNov 20, 2025Insider tradeSEC
144 · Notice of proposed saleNov 18, 2025Other filingsSEC
4 · Change in ownershipNov 12, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 12, 2025Big-stake noticeSEC
4 · Change in ownershipNov 7, 2025Insider tradeSEC
144 · Notice of proposed saleNov 7, 2025Other filingsSEC
144 · Notice of proposed saleNov 5, 2025Other filingsSEC
10-Q · Quarterly reportNov 3, 2025Quarterly reportSEC
8-K · Current reportNov 3, 2025ResultsSEC
8-K · Current reportOct 30, 2025Material contractSEC
4 · Change in ownershipOct 29, 2025Insider tradeSEC
4 · Change in ownershipOct 29, 2025Insider tradeSEC
4 · Change in ownershipOct 15, 2025Insider tradeSEC
4 · Change in ownershipOct 15, 2025Insider tradeSEC
4 · Change in ownershipOct 15, 2025Insider tradeSEC
4 · Change in ownershipOct 15, 2025Insider tradeSEC
4 · Change in ownershipOct 15, 2025Insider tradeSEC
4 · Change in ownershipOct 15, 2025Insider tradeSEC
4 · Change in ownershipOct 15, 2025Insider tradeSEC
4 · Change in ownershipOct 15, 2025Insider tradeSEC
4/A · Change in ownership, amendedSep 17, 2025Insider tradeSEC
4 · Change in ownershipSep 17, 2025Insider tradeSEC
144 · Notice of proposed saleSep 15, 2025Other filingsSEC
4 · Change in ownershipSep 5, 2025Insider tradeSEC

This page holds 200 of 710 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Liquidia Corporation’s releases · as of Oct 28, 2026

Common shares
90,106,442
Fully diluted
90,106,442

Fully diluted

LineSharesAs of
Common shares90,106,442Oct 28, 2026

Share count over time

CountShares
Oct 28, 202690,106,442

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
BlackRock11.3M12.5%US$341MSep 30, 2026
Farallon Capital Management, L.L.C.8.91M9.9%US$269MSep 30, 2026
Caligan Partners LP8.12M9.0%US$246MSep 30, 2026
Vanguard6.7M7.4%US$203MSep 30, 2026
Findell Capital Management LLC3.64M4.0%US$110MSep 30, 2026
State Street3.22M3.6%US$97.3MSep 30, 2026
Geode Capital2.17M2.4%US$65.8MSep 30, 2026
Opaleye Management Inc.2.11M2.3%US$63.8MSep 30, 2026
Bank of America1.84M2.0%US$55.5MSep 30, 2026
T. Rowe Price1.77M2.0%US$53.4MSep 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Mpm Bioimpact LLC1.34M1.5%US$40.6MSep 30, 2026
Invesco1.28M1.4%US$38.8MSep 30, 2026
D. E. Shaw & Co., Inc.1.12M1.2%US$33.9MSep 30, 2026
Goldman Sachs1.02M1.1%US$31MSep 30, 2026
Caprock Group, LLC978K1.1%US$29.6MSep 30, 2026
Susquehanna888K0.99%US$26.9MSep 30, 2026
Morgan Stanley798K0.89%US$24.1MSep 30, 2026
Schwab748K0.83%US$22.6MSep 30, 2026
Federated Hermes, Inc.742K0.82%US$22.4MSep 30, 2026
Whitefort Capital Management, LP737K0.82%US$22.3MSep 30, 2026
Northern Trust714K0.79%US$21.6MSep 30, 2026
Eversept Partners, LP642K0.71%US$19.4MSep 30, 2026
Seven Fleet Capital Management LP596K0.66%US$18MSep 30, 2026
Boothbay Fund Management, LLC589K0.65%US$17.8MSep 30, 2026
American Century548K0.61%US$16.6MSep 30, 2026
Principal539K0.60%US$16.3MSep 30, 2026
Public Sector Pension Investment Board459K0.51%US$12.3MSep 30, 2026
Dimensional452K0.50%US$13.8MSep 30, 2026
Fidelity434K0.48%US$13.1MSep 30, 2026
Purewater Capital LLC402K0.45%US$12.2MSep 30, 2026
BNY373K0.41%US$11.3MSep 30, 2026
JPMorgan343K0.38%US$24.5MSep 30, 2026
First Trust317K0.35%US$9.6MSep 30, 2026
UBS315K0.35%US$9.54MSep 30, 2026
Oberweis Asset Management Inc/312K0.35%US$9.45MSep 30, 2026
Sio Capital Management, LLC282K0.31%US$8.53MSep 30, 2026
Buckley Capital Advisors, LLC281K0.31%US$8.51MSep 30, 2026
Quadrature Capital Ltd277K0.31%US$8.39MSep 30, 2026
Janus Henderson258K0.29%US$7.81MSep 30, 2026
Renaissance Technologies243K0.27%US$7.34MSep 30, 2026
Citadel240K0.27%US$7.27MSep 30, 2026
Hrt Financial LP221K0.25%US$6.7MSep 30, 2026
Two Sigma210K0.23%US$6.35MSep 30, 2026
Nuveen200K0.22%US$6.05MSep 30, 2026
Barclays191K0.21%US$5.77MSep 30, 2026
Rhumbline Advisers168K0.19%US$5.08MSep 30, 2026
Legal & General166K0.18%US$5.01MSep 30, 2026
DWS158K0.18%US$4.79MSep 30, 2026
Marshall Wace, LLP155K0.17%US$4.7MSep 30, 2026
Swiss National Bank139K0.15%US$4.22MSep 30, 2026

This page holds 50 of 299 holders. Open Shareholders

Funds

HolderSharesOf the companyValueAs of
iShares Core S&P Small-Cap ETF4.23M4.7%US$337MJun 30, 2026
Vanguard Total Stock Market Index Fund2.26M2.5%US$180MJun 30, 2026
iShares Russell 2000 ETF1.81M2.0%US$144MJun 30, 2026
Fullerthaler Behavioral Small-Cap Growth813K0.90%US$64.8MJun 30, 2026
Vanguard Extended Market Index Fund806K0.89%US$64.3MJun 30, 2026
Fidelity Small Cap Index Fund771K0.86%US$64.9MJul 31, 2026
iShares Russell 2000 Growth ETF651K0.72%US$51.9MJun 30, 2026
State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF644K0.71%US$51.3MJun 30, 2026
iShares S&P Small-Cap 600 Growth ETF631K0.70%US$50.3MJun 30, 2026
T. Rowe Price New Horizons Fund, Inc.522K0.58%US$41.6MJun 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Small Cap Growth Fund414K0.46%US$34.8MJul 31, 2026
State Street(R) SPDR(R) S & P 600(TM) Small Cap Growth ETF399K0.44%US$31.8MJun 30, 2026
Oberweis Micro-Cap Fund392K0.44%US$31.3MJun 30, 2026
Vanguard Tax-Managed Small-Cap Fund388K0.43%US$30.9MJun 30, 2026
T. Rowe Price Health Sciences Fund, Inc.365K0.41%US$29.1MJun 30, 2026
T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund359K0.40%US$28.6MJun 30, 2026
Fidelity Extended Market Index Fund353K0.39%US$21.9MMay 31, 2026
Vanguard Russell 2000 Index Fund336K0.37%US$20.8MMay 31, 2026
Federated Hermes MDT Small Cap Core Fund331K0.37%US$27.8MJul 31, 2026
Schwab U.S. Small-Cap ETF329K0.37%US$20.4MMay 31, 2026
Fidelity Small Cap Growth Fund228K0.25%US$19.1MJul 31, 2026
Fidelity Enhanced Small Cap Core ETF215K0.24%US$17.1MJun 30, 2026
Fidelity SAI Small-Mid Cap Momentum Index Fund210K0.23%US$17.7MJul 31, 2026
Invesco Pharmaceuticals ETF205K0.23%US$17.3MJul 31, 2026
State Street(R) SPDR(R) S&P Kensho New Economies Composite ETF189K0.21%US$15MJun 30, 2026
Vanguard Health Care Index Fund183K0.20%US$11.3MMay 31, 2026
iShares U.S. Pharmaceuticals ETF183K0.20%US$14.6MJun 30, 2026
Bridge Builder Small/Mid Cap Growth Fund181K0.20%US$14.4MJun 30, 2026
Schwab Small-Cap Index Fund171K0.19%US$14.4MJul 31, 2026
Federated Hermes MDT Small Cap Growth Fund167K0.19%US$14MJul 31, 2026
Vanguard Explorer Fund167K0.19%US$14MJul 31, 2026
Janus Henderson Small/Mid Cap Growth Alpha ETF158K0.17%US$13.3MJul 31, 2026
U.S. Small Cap Portfolio155K0.17%US$13.1MJul 31, 2026
Master Small Cap Index Series130K0.14%US$10.4MJun 30, 2026
Fidelity Total Market Index Fund130K0.14%US$8.02MMay 31, 2026
Fidelity Small Cap Growth K6 Fund114K0.13%US$9.55MJul 31, 2026
Alpha Architect U.S. Quantitative Momentum ETF110K0.12%US$8.79MJun 30, 2026
First Trust Small Cap Growth AlphaDEX Fund110K0.12%US$9.26MJul 31, 2026
JNL Small Cap Index Fund110K0.12%US$8.77MJun 30, 2026
Fidelity Series Total Market Index Fund105K0.12%US$6.5MMay 31, 2026
State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF100K0.11%US$7.99MJun 30, 2026
iShares U.S. Small-Cap Equity Factor ETF97,9590.11%US$8.24MJul 31, 2026
Nuveen Small Cap Blend Index Fund92,0490.10%US$7.74MJul 31, 2026
iShares Core S&P Total U.S. Stock Market ETF89,0020.10%US$7.1MJun 30, 2026
Invesco Dorsey Wright Healthcare Momentum ETF84,2340.09%US$7.08MJul 31, 2026
Nuveen Equity Index Fund77,3840.09%US$6.51MJul 31, 2026
EQ/2000 Managed Volatility Portfolio76,5410.08%US$6.1MJun 30, 2026
Tax-Managed U.S. Mid & Small Cap Fund67,9600.08%US$5.72MJul 31, 2026
Fidelity Small Cap Growth Index Fund66,1310.07%US$5.27MJun 30, 2026
Fidelity Small-Mid Multifactor ETF64,5490.07%US$5.43MJul 31, 2026

This page holds 50 of 268 holders. Open Shareholders

Insider trades

TradeTradeSharesPriceValueDate
Adair Jason
Officer: Chief Business Officer
Sale688USD 43.19US$29,715Oct 26, 2026
Boyle Dana
Officer: Chief Accounting Officer
Sale1,581USD 43.19US$68,283Oct 26, 2026
Adair Jason
Officer: Chief Business Officer
Sale7,301USD 28.48US$208KOct 12, 2026
Boyle Dana
Officer: Chief Accounting Officer
Sale5,892USD 28.48US$168KOct 12, 2026
Jeffs Roger
Director, Officer: Chief Executive Officer
Sale32,744USD 28.48US$933KOct 12, 2026
Kaseta Michael
Officer: CFO and COO
Sale18,938USD 28.48US$539KOct 12, 2026
Khindri Sanjeev
Officer: Chief Development Officer
Sale1,101USD 28.48US$31,356Oct 12, 2026
Krepp Sarah
Officer: Chief Human Resource Officer
Sale5,245USD 28.48US$149KOct 12, 2026
Moomaw Scott
Officer: Chief Commercial Officer
Sale8,863USD 28.48US$252KOct 12, 2026
Saggar Rajeev
Officer: Chief Medical Officer
Sale9,218USD 28.48US$263KOct 12, 2026
Show 50 trades
TradeTradeSharesPriceValueDate
Schundler Russell
Officer: General Counsel
Sale13,692USD 28.48US$390KOct 12, 2026
Bloch Stephen M
Director
Sale235,477USD 27.13US$6.39MOct 5, 2026
Singh Raman
Director
Sale8,468USD 66.16US$560KSep 14, 2026
Singh Raman
Director
Sale9,024USD 68.62US$619KSep 11, 2026
Krepp Sarah
Officer: Chief Human Resource Officer
Sale274USD 67.76US$18,566Sep 1, 2026
Adair Jason
Officer: Chief Business Officer
Sale31,799USD 69.09US$2.2MAug 21, 2026
Adair Jason
Officer: Chief Business Officer
Sale41,832USD 69.09US$2.89MAug 21, 2026
Rielly-Gauvin Katherine
Director
Sale18,393USD 72.23US$1.33MAug 20, 2026
Rielly-Gauvin Katherine
Director
Sale36,789USD 74.99US$2.76MAug 19, 2026
Saggar Rajeev
Officer: Chief Medical Officer
Sale50,000USD 74.06US$3.7MAug 19, 2026
Saggar Rajeev
Officer: Chief Medical Officer
Sale29,534USD 76.84US$2.27MAug 17, 2026
Adair Jason
Officer: Chief Business Officer
Sale688USD 87.53US$60,221Jul 27, 2026
Boyle Dana
Officer: Chief Accounting Officer
Sale1,600USD 87.53US$140KJul 27, 2026
Bloch Stephen M
Director
Sale96,400USD 89.44US$8.62MJul 23, 2026
Bloch Stephen M
Director
Sale3,600USD 90.71US$327KJul 23, 2026
Bloch Stephen M
Director
Sale37,406USD 87.70US$3.28MJul 22, 2026
Bloch Stephen M
Director
Sale48,032USD 88.65US$4.26MJul 22, 2026
Bloch Stephen M
Director
Sale14,562USD 89.24US$1.3MJul 22, 2026
Bloch Stephen M
Director
Sale74,444USD 79.98US$5.95MJul 21, 2026
Bloch Stephen M
Director
Sale556USD 80.66US$44,847Jul 21, 2026
Bloch Stephen M
Director
Sale3,596USD 79.55US$286KJul 20, 2026
Boyle Dana
Officer: Chief Accounting Officer
Sale641USD 71.39US$45,761Jul 13, 2026
Boyle Dana
Officer: Chief Accounting Officer
Sale8,361USD 71.52US$598KJul 13, 2026
Moomaw Scott
Officer: Chief Commercial Officer
Sale675USD 71.39US$48,188Jul 13, 2026
Moomaw Scott
Officer: Chief Commercial Officer
Sale8,864USD 71.52US$634KJul 13, 2026
Saggar Rajeev
Officer: Chief Medical Officer
Sale703USD 71.39US$50,187Jul 13, 2026
Saggar Rajeev
Officer: Chief Medical Officer
Sale9,223USD 71.52US$660KJul 13, 2026
Schundler Russell
Officer: General Counsel
Sale1,046USD 71.39US$74,674Jul 13, 2026
Schundler Russell
Officer: General Counsel
Sale13,692USD 71.52US$979KJul 13, 2026
Adair Jason
Officer: Chief Business Officer
Sale562USD 71.39US$40,121Jul 13, 2026
Adair Jason
Officer: Chief Business Officer
Sale7,301USD 71.52US$522KJul 13, 2026
Jeffs Roger
Director, Officer: Chief Executive Officer
Sale2,505USD 71.39US$179KJul 13, 2026
Jeffs Roger
Director, Officer: Chief Executive Officer
Sale32,744USD 71.52US$2.34MJul 13, 2026
Kaseta Michael
Officer: CFO and COO
Sale1,453USD 71.39US$104KJul 13, 2026
Kaseta Michael
Officer: CFO and COO
Sale18,977USD 71.52US$1.36MJul 13, 2026
Khindri Sanjeev
Officer: Chief Development Officer
Sale84USD 71.39US$5,997Jul 13, 2026
Khindri Sanjeev
Officer: Chief Development Officer
Sale1,101USD 71.52US$78,744Jul 13, 2026
Krepp Sarah
Officer: Chief Human Resource Officer
Sale558USD 71.39US$39,836Jul 13, 2026
Krepp Sarah
Officer: Chief Human Resource Officer
Sale7,306USD 71.52US$523KJul 13, 2026
Bloch Stephen M
Director
Sale22,718USD 80.48US$1.83MJul 7, 2026

This page holds 50 of 139 trades. Open Shareholders

Big stakes

StakeStakeSharesDateFiling
BlackRock, Inc.11.90%10.6MJun 30, 2026Schedule 13G
Farallon Capital Management, L.L.C.9.40%8.37MJun 30, 2026Schedule 13G
Paul B Manning6.50%4.95MJun 30, 2026Schedule 13G
IsZo Capital LP5.20%4.71MNov 12, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Paul B. Manning
Other companies: Candel Therapeutics, Inc. (Chair of the Board · Since at least Jul 26, 2021); Verrica Pharmaceuticals Inc. (Chairman · Since at least Jun 14, 2018); Taysha Gene Therapies, Inc. (Director · Sep 23, 2020 – Oct 31, 2022 · Past); Dova Pharmaceuticals Inc (Director · Jun 28, 2017 – Nov 12, 2019 · Past); AveXis Inc (Director · Feb 10, 2016 – Feb 10, 2016 · Past); Perrigo Company plc (EVP & General Manager, PBM · Jun 9, 2010 – Jun 9, 2010 · Past)
Board Member · Since at least Nov 18, 2020
Roger Jeffs
Other companies: Axsome Therapeutics, Inc. (DIRECTOR · Since at least Nov 19, 2015); Sio Gene Therapies Inc (Director · Feb 8, 2018 – Apr 15, 2019 · Past); Albireo Pharma Inc (Director · Sep 27, 2017 – Jun 24, 2021 · Past); Dova Pharmaceuticals Inc (Director · Jun 28, 2017 – Nov 12, 2019 · Past); Sangamo Therapeutics, Inc. (Director · Jun 26, 2017 – Sep 7, 2018 · Past); United Therapeutics Corporation (President & Co-CEO, Director · Jan 5, 2006 – Mar 15, 2016 · Past)
Chief Executive Officer · Since at least Nov 18, 2020
Arthur Kirsch
Other companies: Evommune, Inc. (Audit · Since at least Nov 5, 2025); Atea Pharmaceuticals, Inc. (Director · Since at least Feb 20, 2025); Kadmon Holdings Inc (Director · May 15, 2019 – Nov 9, 2021 · Past); Aralez Pharmaceuticals Inc (Director · May 12, 2016 – Dec 8, 2017 · Past)
Board Member · Since at least Mar 24, 2021
Michael Kaseta
Other companies: Heron Therapeutics, Inc. (Director · Since at least Nov 4, 2024); Alimera Sciences Inc (Director · Mar 24, 2023 – Sep 16, 2024 · Past); Aralez Pharmaceuticals Inc (Chief Financial Officer · Nov 30, 2017 – Mar 15, 2018 · Past)
CFO and COO · Since at least Nov 30, 2020
Stephen Bloch
Other companies: Marinus Pharmaceuticals Inc (Director · Jul 31, 2014 – Sep 24, 2015 · Past); Amicus Therapeutics Inc (Director · May 30, 2007 – Feb 11, 2009 · Past)
Chairman · Since at least Mar 24, 2021
Joanna Horobin
Other companies: Kymera Therapeutics, Inc. (Director · Jun 7, 2024 – Jun 7, 2024 · Past)
Director · Since at least Jun 20, 2024
Damian deGoaDirector · Since at least Jun 17, 2025
Dana BoyleChief Accounting Officer · Since at least Jul 1, 2025
David JohnsonDirector · Since at least May 19, 2026
Harold AltersonSee Remarks · Since at least Nov 16, 2026
All 22 people
PersonSeat
Jason AdairChief Business Officer · Since at least Jul 21, 2021
Katherine Rielly-GauvinDirector · Since at least Jun 16, 2026
Katie Rielly-GauvinBoard Member · Since at least Aug 21, 2026
Patrick WallaceDirector, Corporate Communications · Since at least Jan 27, 2026
Rajeev SaggarChief Medical Officer · Since at least Jul 18, 2022
Raman SinghBoard Member · Since at least Mar 24, 2021
Robert A LippeChief Operations Officer · Nov 30, 2023 – Nov 30, 2023 · Past
Russell SchundlerSee Remarks · Since at least Mar 29, 2021
Sanjeev KhindriChief Development Officer · Since at least Jan 1, 2026
Sarah KreppChief Human Resource Officer · Since at least Jul 1, 2025
Scott MoomawChief Commercial Officer · Since at least Nov 18, 2020
Tushar ShahCMO and Head of R&D · Jan 19, 2021 – Jan 16, 2022 · Past

Open People

Log in to ask 6ix AI your own questions about Liquidia Corporation.